These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37792273)

  • 21. Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®).
    Gold LS; Schepman PB; Wang WJ; Philbin M; Niewoehner J; Damal K; Hansen RN
    Adv Ther; 2016 Aug; 33(8):1293-304. PubMed ID: 27324137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
    Hladunewich MA; Cattran D; Beck LH; Odutayo A; Sethi S; Ayalon R; Leung N; Reich H; Fervenza FC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1570-7. PubMed ID: 24714414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis.
    Busch H; Wan GJ; Niewoehner J; Houston P; Su Y; Clinton C; Panaccio MP
    Drugs Context; 2022; 11():. PubMed ID: 35382109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States.
    Nelson WW; Philbin MJ; Gallagher JR; Heap K; Carroll S; Wan GJ
    Rheumatol Ther; 2017 Dec; 4(2):465-474. PubMed ID: 29071588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis.
    Fleischmann R; Furst DE
    Expert Opin Drug Saf; 2020 Aug; 19(8):935-944. PubMed ID: 32497440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists.
    Huang YJ; Galen K; Zweifel B; Brooks LR; Wright AD
    J Recept Signal Transduct Res; 2021 Oct; 41(5):425-433. PubMed ID: 32938265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
    BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report.
    Madan A
    Int J Gen Med; 2015; 8():119-24. PubMed ID: 25848316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar
    Askanase AD; Wan GJ; Panaccio MP; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2021 Mar; 8(1):573-584. PubMed ID: 33687687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus.
    Askanase AD; Wright D; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2021 Dec; 8(4):1871-1886. PubMed ID: 34478124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept.
    Decker DA; Higgins P; Hayes K; Bollinger C; Becker P; Wright D
    BMC Musculoskelet Disord; 2020 Aug; 21(1):586. PubMed ID: 32867752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bio-equivalence of IM and SQ H.P. Acthar Gel.
    Brod SA; Morales MM
    Biomed Pharmacother; 2009 May; 63(4):251-3. PubMed ID: 18848765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.
    Simsarian JP; Saunders C; Smith DM
    Drug Des Devel Ther; 2011; 5():381-9. PubMed ID: 21792296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acthar Gel Inhibits the Activation of CD4
    Wright D; Hayes K
    J Interferon Cytokine Res; 2023 Apr; 43(4):182-187. PubMed ID: 37062818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms.
    Duchowny MS; Chopra I; Niewoehner J; Wan GJ; Devine B
    J Health Econ Outcomes Res; 2021 Jan; 8(1):1-9. PubMed ID: 33521161
    [No Abstract]   [Full Text] [Related]  

  • 37. Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies.
    Patel A; Seely G; Aggarwal R
    Case Rep Rheumatol; 2016; 2016():9068061. PubMed ID: 27642533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up results of myositis patients treated with H. P. Acthar gel.
    Saygin D; Oddis CV; Marder G; Moghadam-Kia S; Nandkumar P; Neiman N; Dzanko S; Koontz D; Aggarwal R
    Rheumatology (Oxford); 2020 Oct; 59(10):2976-2981. PubMed ID: 32160301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar Gel) for nephrotic syndrome.
    Rice JB; Panaccio MP; White A; Simes M; Billmyer E; Downes N; Niewoehner J; Wan GJ
    Curr Med Res Opin; 2021 Mar; 37(3):431-441. PubMed ID: 33411573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenocorticotropic Hormone in the Treatment of Focal Segmental Glomerulosclerosis Following Kidney Transplantation.
    Grafals M; Sharfuddin A
    Transplant Proc; 2019; 51(6):1831-1837. PubMed ID: 31399168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.